Of 19,286 patients hospitalized in winter, the risk of death was higher from COVID-19 than flu (adjusted rate ratio [aRR], ...
the team created nine nanobodies to fight COVID-19. Now, they've used this technology to develop two new nanobody inhibitors for Ebola: Nanosota-EB1 and Nanosota-EB2. The nanobodies work in ...
the team created nine nanobodies to fight COVID-19. Now, they've used this technology to develop two new nanobody inhibitors for Ebola: Nanosota-EB1 and Nanosota-EB2. The nanobodies work in ...